Anavex Life Sciences Ownership | Who Owns Anavex Life Sciences?


OverviewForecastFinancialsChartTranscripts

Anavex Life Sciences Ownership Summary


Anavex Life Sciences is owned by 37.86% institutional investors, 3.31% insiders, and 58.82% retail investors. Blackrock funding, inc. /de is the largest institutional shareholder, holding 8.20% of AVXL shares. Vanguard US Total Market Shares ETF is the top mutual fund, with 2.98% of its assets in Anavex Life Sciences shares.

AVXL Ownership Benchmark


TypeName% Inst% Insiders% Retail
StockAnavex Life Sciences37.86%3.31%58.82%
SectorHealthcare Stocks 488.17%11.08%-399.26%
IndustryBiotech Stocks 306.59%11.10%-217.69%

Institutional Shareholders


Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Blackrock funding, inc. /de7.00M8.20%$64.56M
Blackrock6.39M7.75%$26.97M
Vanguard group4.68M5.61%$50.27M
State street2.41M2.84%$25.90M
Geode capital management1.87M2.25%$20.14M
Susquehanna group, llp1.13M1.36%$12.19M
Nwam1.02M1.20%$11.44M
Two sigma investments, lp776.90K0.93%$8.34M
Northern trust669.16K0.81%$2.82M
Charles schwab investment management677.22K0.81%$7.27M

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Nwam1.02M0.93%$11.44M
Pier capital424.15K0.60%$3.91M
Allsquare wealth management52.38K0.27%$482.97K
Corton capital24.52K0.26%$226.05K
Heartland advisors155.85K0.09%$1.67M
Watts gwilliam26.00K0.07%$349.96K
Saxon interests17.85K0.07%$153.14K
Hikari power85.58K0.07%$789.00K
Opus capital group34.70K0.05%$373.00K
Prairiewood capital13.80K0.05%$127.24K

Top Buyers

HolderShares% AssetsChange
Susquehanna group, llp1.13M0.00%896.32K
Invesco615.05K0.00%590.64K
Blackrock funding, inc. /de7.00M0.00%298.14K
Ubs group418.76K0.00%288.71K
Summit financial222.98K0.05%222.98K

Top Sellers

HolderShares% AssetsChange
Wealthgarden f.s.---910.48K
Jupiter asset management---804.64K
State street2.41M0.00%-654.02K
Essential planning, llc.---413.09K
Bank of america corp /de/175.90K0.00%-388.80K

New Positions

HolderShares% AssetsChangeValue
Summit financial222.98K0.05%222.98K$2.06M
Wellington management group llp158.67K0.00%158.67K$1.70M
Heartland advisors155.85K0.09%155.85K$1.67M
Gladstone institutional advisory26.02K0.01%26.02K$279.40K
Watts gwilliam26.00K0.07%26.00K$349.96K

Sold Out

HolderChange
Nelson, van denburg & campbell wealth management group-14.00
Stephens consulting-40.00
Bay harbor wealth management-70.00
Srs capital advisors-87.00
Russell investments group-115.00

Institutional Ownership Trends


DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Jun 30, 2025184-6.60%32,327,9853.05%372.78%89-11.00%35-23.91%
Mar 31, 20253-98.38%406,643-98.62%-0.04%2-98.04%--100.00%
Dec 31, 202418017.65%29,442,0845.60%343.11%9838.03%3822.58%
Sep 30, 20241511.34%27,864,8824.09%323.13%7216.13%30-33.33%
Jun 30, 2024148-6.33%26,770,748-15.94%322.16%62-17.33%44-

Top Mutual Funds Shareholders


HolderShares% HoldingChange
Vanguard US Total Market Shares ETF2.53M2.98%-
Vanguard Total Stock Mkt Idx Inv2.54M2.97%-56.28K
iShares Russell 2000 ETF1.98M2.32%-37.59K
SPDR® S&P Biotech ETF1.12M1.31%27.55K
Vanguard Institutional Extnd Mkt Idx Tr920.50K1.08%-413.65K
Fidelity Small Cap Index839.44K0.98%77.86K
Invesco Biotechnology & Genome ETF826.28K0.97%-
iShares Russell 2000 Growth ETF737.08K0.86%-
iShares Biotechnology ETF509.07K0.60%4.35K
iShares Russell 2000 Value ETF507.79K0.59%-

Recent Insider Transactions


DateNameRoleActivityValue
Jun 14, 2024Donhauser Peter D.O.-Buy$10.32K
May 15, 2024Thomas Steffen-Buy$22.60K
Mar 28, 2024MISSLING CHRISTOPHER U President and CEOSell$374.97K
Jun 28, 2023MISSLING CHRISTOPHER U President and CEOSell$2.14M
May 25, 2022Skarpelos Athanasios Sell$453.00K

Insider Transactions Trends


DateBuySell
2025 Q3--
2025 Q2--
2025 Q1--
2024 Q4--
2024 Q22-

AVXL Ownership FAQ


Who Owns Anavex Life Sciences?

Anavex Life Sciences shareholders are primarily institutional investors at 37.86%, followed by 3.31% insiders and 58.83% retail investors. The average institutional ownership in Anavex Life Sciences's industry, Biotech Stocks , is 306.59%, which Anavex Life Sciences falls below.

Who owns the most shares of Anavex Life Sciences?

Anavex Life Sciences’s largest shareholders are Blackrock funding, inc. /de (7M shares, 8.20%), Blackrock (6.39M shares, 7.75%), and Vanguard group (4.68M shares, 5.61%). Together, they hold 21.56% of Anavex Life Sciences’s total shares outstanding.

Does Blackrock own Anavex Life Sciences?

Yes, BlackRock owns 7.75% of Anavex Life Sciences, totaling 6.39M shares as of Jun 2024. This represents 0.00% of BlackRock's total assets, with a market value of 26.97M$. In the last quarter, BlackRock decreased its holdings by -254K shares, a -3.82% change.

Who is Anavex Life Sciences’s biggest shareholder by percentage of total assets invested?

Nwam is Anavex Life Sciences’s biggest shareholder by percentage of total assets invested, with 0.93% of its assets in 1.02M Anavex Life Sciences shares, valued at 11.44M$.

Who is the top mutual fund holder of Anavex Life Sciences shares?

Vanguard US Total Market Shares ETF is the top mutual fund holder of Anavex Life Sciences shares, with 2.98% of its total shares outstanding invested in 2.53M Anavex Life Sciences shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools